On 8 February, Huntington Bancshares Incorporated (NASDAQ:HBAN) reported net income for the 2014 fourth quarter of $164 million, a $9 million and $5 million increase from the prior and year-ago quarters, respectively. On Monday shares of Huntington Bancshares Incorporated (NASDAQ:HBAN) closed at $10.37. Company’s sales growth for last 5 years was -2.50% and EPS growth for next 5 years is recorded as 8.44%.
On 29 January, The Procter & Gamble Company (NYSE:PG) said that it will run a 60-second version of its lauded “Like A Girl” ad during Super Bowl XLIX. The Procter & Gamble Company (NYSE:PG) in last trading activity decreased -0.65% to close at $85.05. Company weekly performance is -0.08% while its quarterly performance stands at -3.65%. The Procter & Gamble Company (NYSE:PG) is -8.77% away from its 52 week high.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) said that it is scheduled to release its fourth-quarter 2014 financial results before the opening bell on Feb 10, 2015. On last trading day Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) fell -1.75% to close at $399.72. Its volatility for the week is 3.29% while volatility for the month is 3.21%. REGN’s sales growth for past 5 years was 54.60% and its EPS growth for past 5 years was 42.20%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) monthly performance is -0.88%.
On 8 February, Merck & Co. Inc. (NYSE:MRK) has joined Novartis, Pfizer and a host of other Big Pharma companies in the Structural Genomics Consortium (SGC), a transatlantic public-private collaboration focused on the 3-D structures of proteins. On last trading day Merck & Co. Inc. (NYSE:MRK) fell -0.78% to close at $58.33. Its volatility for the week is 2.01% while volatility for the month is 2.04%. MRK’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was -16.50%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -7.19%.
Equities researchers at Deutsche Bank increased their price objective on shares of LyondellBasell Industries N.V. (NYSE:LYB) from $90.00 to $96.00 in a research report issued on Wednesday. The firm currently has a “buy” rating on the stock. Deutsche Bank’s price objective indicates a potential upside of 12.48% from the company’s current price. On last trading day LyondellBasell Industries N.V. (NYSE:LYB) advanced 1.75% to close at $88.34. Its volatility for the week is 3.29% while volatility for the month is 3.78%. LYB’s sales growth for past 5 years was -2.80% and its EPS growth for past 5 years was 20.30%. LyondellBasell Industries N.V. (NYSE:LYB) monthly performance is 12.94%.